Form 4: Nuvalent Insiders Report Acquisition of Shares and Options Through Compensation Grants

James E. Flynn and Deerfield Management Company, L.P. reported the acquisition of Nuvalent, Inc. Class A Common Stock and stock options through compensation grants to affiliated directors.

Summary

• James E. Flynn and Deerfield Management Company, L.P. filed a Form 4 reporting changes in beneficial ownership of Nuvalent, Inc. securities.
• The filing details the acquisition of 2,647 shares of Class A Common Stock each for Cameron Wheeler and Joseph Pearlberg, both directors affiliated with Deerfield Management, granted as Restricted Stock Units (RSUs) at a price of $0.
• Additionally, 4,147 stock options each were granted to Mr. Wheeler and Mr. Pearlberg, with an exercise price of $75.53 per share.
• These RSUs and stock options are held for the benefit and at the direction of Deerfield Management Company, L.P.
• The RSUs and options granted on June 18, 2025, are scheduled to vest on the earlier of June 18, 2026, or the date of Nuvalent's next annual meeting of stockholders, subject to continued service.
• Deerfield Management Company, L.P. and James E. Flynn, as the sole member of the general partner of various Deerfield entities, are identified as 10% owners and directors by deputization.
• The filing also notes existing indirect beneficial ownership of Class A Common Stock through various Deerfield funds, totaling 4,998 shares (fully vested RSUs), 650,000 shares (Deerfield Partners, L.P.), 8,670,512 shares (Deerfield Private Design Fund IV, L.P.), and 8,670,512 shares (Deerfield Healthcare Innovations Fund, L.P.).

Sentiment

Score: 5

Explanation: Neutral. This is a routine Form 4 filing reporting insider compensation grants, which is a standard corporate event and does not inherently indicate positive or negative sentiment about the company's performance or outlook.

Positives

• Grants of RSUs and stock options to directors align their interests with long-term company performance.
• The continued service requirement for vesting incentivizes retention of key personnel affiliated with a significant investor.

Negatives

• The issuance of new shares upon RSU vesting and option exercise could lead to minor dilution for existing shareholders.

Risks

• Vesting of RSUs and options is subject to continued service, meaning the benefits are contingent on the directors remaining with the Issuer.

Future Outlook

The future outlook indicates that the granted RSUs and stock options are set to vest on the earlier of June 18, 2026, or the date of the Issuer's next annual meeting of stockholders, contingent on the continued service of the affiliated directors.

Management Comments

• "Cameron Wheeler, a partner in Deerfield Management Company, L.P., serves as a director of the Issuer. The reported shares of Class A Common Stock are issuable under restricted stock units ('RSUs') granted to Mr. Wheeler, which are held for the benefit, and at the direction, of Deerfield Management."
• "Joseph Pearlberg, an employee of Deerfield Management, serves as a director of the Issuer. The reported shares of Class A Common Stock are issuable under restricted stock units ('RSUs') granted to Mr. Pearlberg, which are held for the benefit, and at the direction, of Deerfield Management."
• "The option was granted to Mr. Wheeler on June 18, 2025 and is scheduled to vest and become exercisable on the earlier of June 18, 2026 and the date of the Issuer's next annual meeting of stockholders, subject to Mr. Wheeler's continued service to the Issuer through the applicable vesting date. Such Option is held for the benefit, and at the direction, or Deerfield Management."
• "The option was granted to Mr. Pearlberg on June 18, 2025 and is scheduled to vest and become exercisable on the earlier of June 18, 2026 and the date of the Issuer's next annual meeting of stockholders, subject to Mr. Pearlberg's continued service to the Issuer through the applicable vesting date. Such Option is held for the benefit, and at the direction, or Deerfield Management."
• "For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."

Industry Context

This Form 4 filing is a routine disclosure of insider equity compensation, common across publicly traded companies, particularly in the biotechnology or pharmaceutical sector like Nuvalent, Inc., to align management and significant investor interests with company performance. It does not provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• The granting of Restricted Stock Units (RSUs) and stock options as part of director compensation is a standard practice in the biotechnology and pharmaceutical industry, similar to compensation structures observed at comparable companies.
• The vesting schedule tied to continued service and future annual meetings is also typical for incentivizing long-term commitment. Specific comparable companies or projects are not detailed in this filing, as it focuses solely on insider ownership changes.

Corporate Governance

Related Party Transactions

• Grants of Restricted Stock Units and stock options to Cameron Wheeler and Joseph Pearlberg, who are directors of Nuvalent, Inc. and also partners/employees of Deerfield Management Company, L.P., a significant shareholder. These transactions are for the benefit and at the direction of Deerfield Management.

Stakeholder Impact

• Shareholders: Potential minor dilution from the issuance of new shares upon RSU vesting and option exercise, but also alignment of insider interests with long-term shareholder value.
• Employees (Directors): Receipt of equity compensation incentivizes continued service and performance.

Next Steps

• Vesting of granted RSUs and stock options on the earlier of June 18, 2026, or the date of the Issuer's next annual meeting of stockholders.
• Potential exercise of stock options by June 18, 2035, if they become in-the-money.

Key Dates

Keywords

Nuvalent Inc., NUVL, SEC Form 4, Beneficial Ownership, Insider Trading, Restricted Stock Units, RSUs, Stock Options, Deerfield Management, Director Compensation, Equity Grants, Insider Filings